Healthcare And Marijuana Stocks See Common Ground After Elections

Premier Health Group, Inc.

CORAL GABLES, FL / ACCESSWIRE / November 7,2018 / Healthcare stocks have been trending higher ahead of US midterm elections and now that the results are in, sector shares are rallying. The Sector SPDR Healthcare ETF (XLV) has climbed by as much as 5.2% since hitting October lows of $86.27. Butrecent progress that the legal marijuana industry has now seen, could up the ante for companies hovering on theboarders of healthcare & cannabis. Recent news across several marijuana stocks has shown this connection between healthcare and marijuana with several companies planning to expand into this industry and take advantage of its appeal in the medical community Today we're taking a closer look at 3 stocks in the space including Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Aphria (APHA) (APHQF) (APH) and Cronos Group (CRON) (CRON.TO).

Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI) announced this week that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019. With Premier's acquisition of HealthVue Medical Clinics in August, this could be the next phase of growth for the company. Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI) entered the primary care clinic and healthcare technology business via the HealthVue transaction and obtained access to a group of four Greater Vancouver-based fully integrated, paperless and electronic-medical-record-based medical clinics with a 10-year history, 22 healthcare professionals and over 100,000 active patients.

Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI) is actively reviewing a pipeline of additional pharmacy partners, which include bricks and mortar locations for acquisition and strategic new retail opportunities for pharmacies. ''It is our position that the emergence of technology such as the ability for patients to electronically send their prescription(s) to a pharmacy for fulfillment and pick up at a later time or delivery directly to them at home or work will result in increased patient and consumer enrollment in apps that offer this type of functionality,'' said Dr. Essam Hamza, CEO of Premier.

As for pharmacies in Canada, some like Shoppers Drug Mart have confirmed filing applications with the Canadian government earlier this year to be a licensed distributor, allowing pharmacists to dispense cannabis at its hundreds of stores across the nation. The pharmacy trend in Canada doesn't appear to be slowing down either.

In previous updates from Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI) the company cited expansionary plans that include ''clinic openings, acquisitions (clinic, technology, patients), cannabis clinic(s) and partnerships.''

Shares of Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI) moved to highs of $0.67 this week as trading volume in the US continued to uphold a week's long bull trend.

For More Information On Premier Health Group, Click Here

Aphria (APHA) (APHQF) (APH) and Perennial Inc., a subsidiary of DATA Communications Management Corp. (TSX: DCM) announced today that they have closed the transaction announced on August 14 to establish a joint venture devoted to creating original, consumer-driven brands and products for the adult-use cannabis market.

"The brands that stand the test of time are the ones created with an understanding of the marketplace, an original and effective answer to a consumer need, and a message that's relevant to people's lives," said Chris Lund, Chief Innovation Officer of Perennial. "We've been the thought leaders behind our clients' brand strategies, creative development and execution for over 25 years – and now we relish the opportunity to create our own brands from scratch with Aphria, an industry-leading partner. We look forward to working with Aphria to bring innovative consumer-centric products and brands to life in the burgeoning cannabis market."

Shares of Aphria gapped up during premarket trading on Wednesday.

For More Information On Aphria, Click Here

Cronos Group (CRON) (CRON.TO) previously announced a partnership with biotech startup Ginkgo Bioworks to work on developing cannabinoids – the active ingredients that give the cannabis its medical and recreational properties – without having to extract it from the marijuana plants. Cronos recently announced that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair.

"We believe that the potential applications of cannabinoids to regulate skin health and treat skin disorders are vast, and we are excited to begin exploring these applications through our partnership with Technion," said Mike Gorenstein, CEO of Cronos Group. "Using rigorous data to develop efficacious topical and transdermal formulations will be key to creating differentiated products that provide quality treatments to our consumers and strengthen our brand portfolio."

Shares of Cronos have followed suit with other marijuana stocks and gapped up during premarket trading on Wednesday.

For More Information On Cronos Group, Click Here

What Is Stock Price (StockPrice.com)?

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for.

StockPrice.com was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (StockPrice.com), you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns www.StockPrice.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns www.StockPrice.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns www.StockPrice.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2018 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid ''500,000'' shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6)Six month restriction is complete on 4/1/2019 we plan to sell the ''500,000'' shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information:

[email protected]

SOURCE: StockPrice.com